Document is current
Any future updates will be listed below
-
Authors
Colonna, Marco https://orcid.org/0000-0001-5222-4987
Holtzman, David M. https://orcid.org/0000-0002-3400-0856
- License Information
-
More Information
Article History
First Online: 2 July 2025
Competing interests
: M.C. is on the scientific advisory boards of Vigil, BioClec and Halyard and consults for Arena Bioworks, Pfizer and Cell Signaling Technology. D.M.H. has equity and is on the scientific advisory board of C2N Diagnostics and is on the scientific advisory boards of Denali, Genentech, Acta and Cajal Therapeutics, and consults for Pfizer, Roche and Switch Therapeutics.
